# Nektar Therapeutics: Lenders, Customers and Owners

> US
>
> 3 links from the documents that the companies file and the register of legal entities, as of 2026-11-13. A commitment is the commitment at the date of the agreement.

Page: https://annalist.io/atlas/nektar-therapeutics/

## Customers (3)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [Baxalta Incorporated Or Takeda P L C](https://annalist.io/atlas/baxalta-incorporated-or-takeda-p-l-c/brief.md) | 45% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |
| [Astra Zeneca Ab](https://annalist.io/atlas/astra-zeneca-ab/brief.md) | 37% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |
| [Pfizer Inc.](https://annalist.io/atlas/pfizer/brief.md) | 12% of the revenue of the supplier, fiscal year ended 31 Dec 2024 | Stated | [1] |

## Source Documents

- [1] Form 10-K for the fiscal year ended 31 December 2025, 13 Mar 2026 (https://www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm)

## Full Data

- [Every link of this entity with its claims (JSON)](https://annalist.io/api/v1/atlas/nektar-therapeutics.json)
- [The map of every entity (JSON)](https://annalist.io/api/v1/atlas.json)
- [Every link in one table (CSV)](https://annalist.io/api/v1/panel/links.csv.gz)

---

Figures come from official filings and are provided as they are, without warranty of accuracy or completeness. They are not investment advice.